Australia markets closed

Ampio Pharmaceuticals, Inc. (AMPE)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3300+0.0790 (+31.47%)
At close: 03:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
2,439
2,439
8,916
11,900
9,172
Selling general and administrative
7,079
7,079
11,466
8,671
6,650
Total operating expenses
9,518
9,518
20,382
20,571
15,834
Operating income or loss
-9,518
-9,518
-20,382
-20,571
-15,834
Total other income/expenses net
538
538
3,825
3,492
-72
Income before tax
-8,632
-8,632
-16,337
-17,075
-15,894
Income from continuing operations
-8,632
-8,632
-16,337
-17,075
-15,894
Net income
-8,632
-8,632
-16,337
-17,075
-15,894
Net income available to common shareholders
-8,632
-8,632
-16,337
-17,075
-15,894
Basic EPS
-11.05
-
-21.68
-27.00
-27.00
Diluted EPS
-11.70
-
-29.32
-30.00
-27.00
Basic average shares
791.522
-
753.615
664.33
576.155
Diluted average shares
791.522
-
753.615
683.21
576.155